Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-25 @ 3:02 AM
NCT ID:
NCT01940133
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed diagnosis of advanced solid tumor for which no therapy of proven efficacy is available.
* Age ≥ 18
* Evidence of tumor progression with measurable or evaluable disease.
* Use of adequate contraceptive measures for male patients.
* Eastern Cooperative Oncology Group (ECOG) Performance Score of 0-1.
* Signed informed consent.
Exclusion Criteria:
* Concomitant anticancer therapy (e.g., chemotherapy, radiotherapy, hormonal, immunotherapy, biological response modifier, signal transduction inhibitors)
* Patients with a history of myocardial infarction or coronary artery bypass within the last 3 years.
* Patients with severe/unstable angina, coronary/peripheral arterial bypass, symptomatic congestive heart failure NYHA Class 3 or 4, hypertension BP\>150/100mmHg.
* Pre-diagnosed diabetes mellitus.
* Fasting glucose \> 7.0 mmol/L or HbA1c \> 6%.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01940133
Study Brief:
Protocol Section:
NCT01940133